1. Zydus Lifesciences
stock logo

43% Buy

Zydus Lifesciences Share Price

ZYDUSLIFE

₹1,076.00-₹10.05 (-0.93%) TodayLast updated on 24 May, 2024 | 03:41 PM IST
₹1,070.00₹1,096.50
L
Show Current Price
H
  • News

  • Company overview

  • Fundamentals

  • Events

  • F&O (Option chain)

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹1,08,271 Crs

Open

₹1,088.95

Close

₹1,086.05

Circuit range

₹1,194.65 - ₹977.45

Day range

₹1,070.00 - ₹1,096.50

Year range

₹498.85 - ₹1,172.50

Volume

27,35,393

Avg. traded

₹1,083.29

Revenue (12m)

₹19,547 Crs

Zydus LifesciencesZydus Lifesciences Limited is an India-based global life sciences company that discovers, develops, manufactures and markets a broad range of healthcare therapies. The Company is engaged in the business of integrated pharmaceutical operations. Its product portfolio includes active pharmaceutical ingredients (API), human formulations, animal health and veterinary, health, and wellness products. Its products include India formulations, Generics and Zydus biologics. The Company's products include Lipaglyn and Bilypsa (Saroglitazar), Ujvira (Trastuzumab emtansine biosimilar), Exemptia (Adalimumab biosimilar), Vivitra (Trastuzumab biosimilar) and Bryxta (Bevacizumab biosimilar). Its Zydus biologics covers various therapeutic areas, such as oncology, autoimmune disease, nephrology, inflammation, rheumatology, hepatology and infectious illnesses, among others. The Company has a global presence and markets its products in the United States, India, Europe and emerging markets.

Zydus Lifesciences Key indicators

arrow

52 week high

₹1,172.50

52 week low

₹498.85

P/E ratio

28.38

P/B ratio

5.3

ROE

11.38%

ROCE

13.45%

Dividend yield

0.6%

Debt/Equity ratio

0.35

EPS

15.11

Learn more

Investment checklist: (3/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Analyst ratings:

Buy

arrow

Buy

43%

Hold

39%

Sell

18%

This analysis is based on the reviews of 28 experts in the last 7 days

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

34.43%

Net profit margin

17.53%

ROE

11.38%

ROA

7.11%

ROCE

13.45%

Learn more

Zydus Lifesciences Shareholder returns

arrow

1 day

-0.93%

1 week

+2.34%

1 month

+15.27%

3 months

+16.54%

1 year

+113.51%

3 years

+73.20%

5 years

+325.63%

Revenue statement

All values are in ₹ Crores (Cr)
arrow

Cash flow

All values are in ₹ Crores (Cr)
arrow

Balance sheet

All values are in ₹ Crores (Cr)
arrow

Zydus Lifesciences Share Price history

arrow
DayOpenCloseDay’s change
Fri, May 24 2024
₹1,088.95
₹1,076.00
-0.93%
Thu, May 23 2024
₹1,090.00
₹1,086.05
+0.50%
Wed, May 22 2024
₹1,094.00
₹1,080.65
-0.71%
Tue, May 21 2024
₹1,121.10
₹1,088.35
-1.41%
Sat, May 18 2024
₹1,103.95
₹1,103.95
+5.00%
Fri, May 17 2024
₹1,014.95
₹1,051.40
+4.20%
Thu, May 16 2024
₹997.05
₹1,009.00
+1.20%
Wed, May 15 2024
₹991.90
₹997.05
+1.36%

Shareholding info

arrow

Promoters (74.98%)

Mutual Funds (6.71%)

Retail and other (6.66%)

Foreign institutions-FII (5.72%)

Other domestic institutions (5.92%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹6/share

    Ex date 28 Jul 2023

    expand tab
  • Dividend • ₹2.5/share

    Ex date 28 Jul 2022

    expand tab
  • Dividend • ₹0/share

    Ex date

    expand tab

Learn more

Frequently asked questions